Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial
Blonde, Lawrence, Bailey, Timothy S., Chao, Jason, Dex, Terry A., Frias, Juan Pablo, Meneghini, Luigi F., Roberts, Michelle, Aroda, Vanita R.Language:
english
Journal:
Advances in Therapy
DOI:
10.1007/s12325-019-01033-1
Date:
July, 2019
File:
PDF, 550 KB
english, 2019